Cipla also has an Over the Counter (OTC) business wherein it sells multiple products such as Cofsils, Ciphands, Nicotex, Omnigel and Maxirich. Listing Shares of Cipla are listed on BSE ...

Cipla is facing moderate headwinds at the moment. India business underwent a soft two quarters, US business faced supply issues in one main product and Trump tariff pressure has impacted the ...

Bonus Oct 18, 1999 Nov 05, 1999 Oct 07, 1999 Bonus Ratio: 2 share(s) for every 1 shares held Rights Feb 03, 1995 Mar 02, 1995 May 03, 1995 Rights ratio: 4 share for every 50 held at a price of Rs ...

Revenue 7,072.97 7,051.02 6,693.94 6,163.24 ...

Revenue 25,774.09 22,753.12 21,763.34 19,159.59 ...

The Listing Page of Cipla Ltd. presents the Incorporation Date, Public Issue Date, Book Closure dates, Face Value, Key Listing information, Indices it is a part of, and the Exchanges where the company ...

Rx to OTC (Prescription to Over-the-Counter) Switch is the regulatory process by which a previously prescribed drug (Rx) is re-classified and approved for over-the-counter (OTC) sale without ...

VWAP, or volume-weighted average price, is a technical analysis tool used primarily on intraday charts. It provides a benchmark for the average price a security has traded at during the day ...

According to Cipla, the regulatory clearance serves as an important landmark in the Company's journey, allowing it to expand the depth of its oncology portfolio and its foothold in the US market ...

Create a list of the investments you want to track.